ANTIDEPRESSANT CONSUMPTION IN TÜRKİYE DURING THE PANDEMIC

Author:

Demirhan Keleş Hilal1ORCID,Bilgener Emrah2ORCID,Keleş Emre1ORCID

Affiliation:

1. HİTİT ÜNİVERSİTESİ

2. Hitit Üniversitesi Sağlık Bilimleri Fakültesi

Abstract

Objective: This study aims to reveal how the restrictions, quarantines, social policies, and implemented measures during the COVID-19 pandemic have affected the consumption of antidepressant drugs in Türkiye. Material and Method: The research was conducted based on the total consumption figures of antidepressant drugs between 2017 and 2022. The necessary data were obtained from IQVIA/Turkey and OECD official sources. Result and Discussion: Our study has shown that antidepressant consumption in Türkiye during the pandemic has increased much more than expected. Additionally, alongside countries where consumption has increased in OECD countries, there are countries where consumption has not been affected. Examining countries' social and economic policies where consumption is unaffected during the pandemic would be beneficial. Türkiye's social and economic policies have proven inadequate in psychologically protecting the country's citizens during the pandemic.

Publisher

Ankara Universitesi Eczacilik Fakultesi Dergisi

Reference35 articles.

1. 1. Askin, R., Bozkurt, Y., Zeybek, Z. (2020). Covid-19 pandemisi: Psikolojik etkileri ve terapötik müdahaleler. İstanbul Ticaret Üniversitesi Sosyal Bilimler Dergisi, 19(37), 304-318.

2. 2. Türkiye Cumhuriyeti Sağlık Bakanlığı. (2021). COVID-19 Nedir? From https://covid19.saglik.gov.tr/TR-66300/covid-19-nedir-.html . Accessed date: 01.08.2023.

3. 3. World Health Organization. (2021a). WHO COVID-19 dashboard. From https://covid19.who.int/. Accessed date: 08.08.2023.

4. 4. World Health Organization. (2021b). WHO COVID-19 dashboard-Türkiye. From https://data.who.int/dashboards/covid19/cases?m49=792&n=c. Accesed ate: 17.08.2023.

5. 5. Murthy, S., Gomersall, C.D., Fowler, R.A. (2020). Care for critically Ill patients with COVID-19. Clinical Review & Education JAMA Insights, 323(15), 1499-1500. [CrossRef]

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3